Patients who have heterozygous familial hypercholesterolemia (HeFH), a condition that causes abnormally raised low-density lipoprotein cholesterol (LDL-C) levels and premature cardiovascular disease, ...

Many patients who still have symptoms weeks or months after recovering from COVID-19 are spending hefty sums to travel for treatments like apheresis and combination antithrombotic therapy that have ...

Clinics across Europe are selling costly experimental treatments to patients with long covid, despite little to no evidence for their benefits. Reading time 3 minutes A new investigative report out ...

In recent years, as many of the diseases for which allogeneic HPC transplantation is indicated are associated with advancing age; this therapy has been increasingly offered to patients in their sixth ...

Dr. Michael Linenberger of Fred Hutchinson Cancer Research Center has been awarded one of the highest honors in the field of apheresis, the medical subspecialty that uses automated methods to separate ...

Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial The study included CAR T-cell ...

Machine-learning analysis identifies factors predicting T cell collection efficiency in CAR T-cell therapy for DLBCL patients. Higher blood volume, not higher circulating T-cell numbers, correlates ...

Autologous peripheral SCT has largely replaced BMT for the treatment of cancer in both adults and children. Cells are collected by apheresis. The technique has been widely used in France since its ...

The commercially available system consists of a continuous flow cell separator that pumps plasma through twin columns containing polyclonal sheep antibodies to human apoB100 coupled with sepharose 4B ...

Approximately 30%-40% of patients with relapsed/refractory (R/R) large B-cell lymphoma (LBCL) infused with CD19-targeted chimeric antigen receptor (CAR) T cells achieve durable responses. Consensus ...